Heron Therapeutics, Inc. /De/

CHARLES SCHWAB INVESTMENT MANAGEMENT INC HRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

1,415,336

Value ($000)

1,840

Weight

0.0%

2014 Q2 - 2025 Q4 (26 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,840	0.0%	1,415,336	12/31/2025
2025 Q3	11/10/2025	1,609	0.0%	1,277,041	9/30/2025
2025 Q2	8/12/2025	2,455	0.0%	1,186,120	6/30/2025
2025 Q1	9/15/2025	2,397	0.0%	1,089,449	3/31/2025
2024 Q4	2/6/2025	1,692	0.0%	1,105,803	12/31/2024
2024 Q3	11/12/2024	2,182	0.0%	1,096,385	9/30/2024
2024 Q2	8/12/2024	3,982	0.0%	1,137,796	6/30/2024
2024 Q1	5/9/2024	3,022	0.0%	1,091,138	3/31/2024
2023 Q4	2/6/2024	1,695	0.0%	997,201	12/31/2023
2023 Q3	11/8/2023	1,012	0.0%	983,009	9/30/2023
2023 Q2	8/10/2023	863	0.0%	743,579	6/30/2023
2023 Q1	5/12/2023	1,104	0.0%	731,126	3/31/2023
2022 Q4	2/13/2023	1,995	0.0%	798,045	12/31/2022
2022 Q3	11/14/2022	3,128	0.0%	741,006	9/30/2022
2022 Q2	8/15/2022	2,040	0.0%	731,055	6/30/2022
2022 Q1	5/13/2022	4,092	0.0%	715,306	3/31/2022
2021 Q4	2/11/2022	6,357	0.0%	696,257	12/31/2021
2021 Q3	11/16/2021	7,446	0.0%	696,526	9/30/2021
2021 Q2	8/16/2021	9,894	0.0%	637,446	6/30/2021
2021 Q1	5/17/2021	9,234	0.0%	569,611	3/31/2021
2020 Q4	2/16/2021	11,720	0.0%	553,741	12/31/2020
2020 Q3	11/13/2020	8,049	0.0%	543,084	9/30/2020
2020 Q2	8/20/2020	7,941	0.0%	539,836	6/30/2020
2020 Q1	5/15/2020	5,852	0.0%	498,460	3/31/2020
2019 Q4	2/7/2020	11,557	0.0%	491,775	12/31/2019
2014 Q2	7/30/2014	352	0.0%	28,500	6/30/2014